Definitions of Sarcopenia

Sarcopenia

Volumn , Issue , 2012, Pages 8-19

  Morley, John E ^a   Cruz Jentoft, Alfonso J ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Body fat (obesity) to muscle mass, confounding factors; Collagen into muscle with aging, muscle mass strength dichotomy; Criteria, sarcopenia diagnosis and categories by cause; Definitions based on muscle mass alone, inherent limitations; EWGSOP conceptual stages of sarcopenia; Muscle mass by itself, a weak outcome predictor; Sarcopenia crucial aspects, overlooked with use of muscle mass; Sarcopenia definition, evolving, reference populations and cutoff values; Sarcopenia, age related in normative ageing, as disease syndrome; Sarcopenia, as a common term in geriatrics gerontology

Indexed keywords

EID: 84877583404     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118338032.ch2     Document Type: Chapter

References (45)

1. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127: 990S-991S.
2. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763.
3. von HS, Morley JE, AnkerSD(2010) An overviewof sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1: 129-133.
4. Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288: 1889-1897.
5. Visser M, Deeg DJ, Lips P, Harris TB, Bouter LM (2000) Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 48: 381-386.
6. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB (2005) Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 60: 324-333.
7. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB (2006) Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61: 72-7.
8. Gale CR, Martyn CN, Cooper C, SayerAA(2007) Grip strength, body composition, and mortality. Int J Epidemiol 36: 228-235.
9. Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, Le Couteur DG, Creasey H, Waite LM, Seibel MJ, Sambrook PN (2010) Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc 58: 2055-2062.
10. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61: 1059-1064.
11. Janssen I, Baumgartner RN, Rss RR, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159: 413-421.
12. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L (2008) Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11: 693-700.
13. Lawler JM, Hindle A (2011) Living in a Box or Call of the Wild? Revisiting Lifetime Inactivity and Sarcopenia. Antioxid Redox Signal.
14. Clark BC, Manini TM (2008) Sarcopenia = / = dynapenia. J Gerontol A Biol Sci Med Sci 63: 829-34.
15. Lupoli L, Sergi G, Coin A, Perissinotto E,Volpato S, Busetto L, Inelmen EM, EnziG(2004) Body composition in underweight elderly subjects: reliability of bioelectrical impedence analysis. Clin Nutr 23: 1371-1380.
16. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896.
17. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris B, Health AS (2003) Sarcopenia: alternative definitions and association with lower extremity function. J Am Geriatr Soc 51: 1602-1609.
18. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
19. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von HS, Yeh SS, Anker SD (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12: 403-409.
20. Cruz-Jentoft AJ, Landi F, Topinkovi E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13: 1-7.
21. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C (2008) The developmental origins of sarcopenia. J Nutr Health Aging 12: 427-432.
22. Laurentani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, DiIorio A, Corsi AM, Rantanen T, Guralnik JM, Ferruci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95: 1851-1860.
23. Rolland Y, Czerwinski S, Bellan van Kan G, Morley JE, Cesari M, Onder G,Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B (2008) Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 12: 433-450.
24. Working Group on Functional Outcome Measures for Clinical Trials (2008) Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 63: 160-164.
25. Thomas DR (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26: 389-399.
26. Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91: 1123S-1127S.
27. Muscaritoli M, Anker SD, Argiles J,Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics. Clin NutrEpub 28. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489-495.
28. Rolland Y, Van Kan GA, Gillette-Guyonnet S, Vellas B (2011) Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 14: 15-21.
29. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D,Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27: 793-799.
30. Morley JE, Anker SD, Evans WJ (2009) Cachexia and aging: an update based on the Fourth International Cachexia Meeting. J Nutr Health Aging 13: 47-55.
31. Abellan van Kan G, Rolland Y, Onder G (2009) Gait speed as a marker of adverse outcomes. J Nutr Health and Aging 13: 881-889.
32. Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, Russo A, Bernabei R, Onder G (2011) Prevalence and Risk Factors of Sarcopenia Among Nursing Home Older Residents. J Gerontol A Biol Sci Med Sci.
33. Vandewoude MF, Cederholm T, Cruz-Jentoft AJ (2011) Relevant outcomes in intervention trials for sarcopenia. J Am Geriatr Soc 59: 1566-1567.
34. Abellan van Kan G, Cameron CW, Gillette-Guyonet S, Houles M, Dupuy C, Rolland Y, Vellas B (2011) Clinical trials on sarcopenia: methodological issues regarding phase 3 trials. Clin Geriatr Med 27: 471-482.
35. Brass EP, Sietsema KE (2011) Considerations in the development of drugs to treat sarcopenia. J Am Geriatr Soc 59: 530-535.
36. Evans CJ, Chiou CF, Fitzgerald KA, Evans WJ, Ferrell BR, Dale W, Fried LP, Gandra SR, nee-Sommers B, Patrick DL (2011) Development of a new patient-reported outcome measure in sarcopenia. J Am Med Dir Assoc 12: 226-233.
37. Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, GallagherD(2004) Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 79: 874-880.
38. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90: 1579-1585.
39. Koster A, Ding J, Stenholm S, Caserotti P, Houston DK, Nicklas BJ, You T, Lee JS, Visser M, Newman AB, SchwartzAV, Cauley JA, Tylavsky FA, Goodpaster BH, Kritchevsky SB, Harris TB (2011) Does the Amount of Fat Mass Predict Age-Related Loss of Lean Mass, Muscle Strength, and Muscle Quality in Older Adults? J Gerontol A Biol Sci Med Sci 66A: 888-895.
40. VisserM(2011) Obesity, sarcopenia and their functional consequences in old age. Proc Nutr Soc 70: 114-118.
41. Fried LP, Tangen CM,Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56: M146-M156.
42. Abellan van KG, Rolland YM, Morley JE, Vellas B (2008) Frailty: toward a clinical definition. J Am Med Dir Assoc 9: 71-72.
43. Bauer JM, Sieber CC (2008) Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol 43: 674-678.
44. Cederholm TE, Bauer JM, Boirie Y, Schneider SM, Sieber CC, Rolland Y (2011) Toward a definition of sarcopenia. Clin Geriatr Med 27: 341-353.
45. Fearon K, Evans WJ, Anker SD (2011) Myopenia-a new universal term for muscle wasting. J Cachex Sarcopenia Muscle 2: 1-3.